Mus vs Yemen: Previously treated cases tested for RR-/MDR-TB (%)
Mus
100.0%
in 2022
Yemen
100.0%
in 2024
Mus rank
1st
Yemen rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Mus
- Yemen
How they compare
Mus currently reports 100.0% against 100.0% in Yemen, a difference of 0.0%.
Across all 15 years both countries report, Mus has been ahead every year.
Mus ranks 1st and Yemen ranks 1st of 2 regions.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 11.2% | 88.8% | Mus |
| 2010s | 95.0% | 21.5% | 73.5% | Mus |
| 2020s | 100.0% | 40.3% | 59.7% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mus or Yemen?
- Mus, at 100.0% against 100.0% in Yemen as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mus and Yemen?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Yemen?
- 15 years are reported by both, from 2006 to 2022.
- How do Mus and Yemen rank globally for previously treated cases tested for rr-/mdr-tb?
- Mus ranks 1st and Yemen ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.